Tag: disorders

Sleep To Live Well Foundation Launches With Groundbreaking Sleep Wellness Report to Tackle National Epidemic and Transform Public Health

SAN JOSE, Calif., July 15, 2025 /PRNewswire/ -- The Sleep To Live Well Foundation issues an urgent warning in its groundbreaking 2025 State of...

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors

Cardiff, United Kingdom – 15 July 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today announces the appointment of Douglas E. Williams, Ph.D. as independent Chair of its Board of Directors. He takes over from Ruth McKernan, who retains her role on the Board as a Director and Interim Chief Executive Officer (CEO).

Topflight Pharma Development Veteran Joins Synendos

Dr. George Garibaldi is named Chief Medical Officer as Synendos transitions from Phase 1 into Phase 2 of its clinical development strategy.

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society’s Annual...

Adult and pediatric patients with classic congenital adrenal hyperplasia treated with CRENESSITY® (crinecerfont) achieved clinically meaningful weight reductionsSubstantial improvements in insulin resistance were also...

SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025

SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the second quarter of 2025 after market close on Monday, August 4, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Regrowing hearing cells: New gene functions discovered in zebrafish offer clues for future hearing loss treatments

Stowers scientists identify specific genes involved in zebrafish sensory hair cell regrowth, providing new insights that could inform future research into hearing loss treatments KANSAS...

Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform

Validates technological prowess of GAIA platform and intensifies global co-development effort, including the existing partnership with Lilly Catalyze360-ExploR&DFunds to accelerate Alzheimer's and immune disease...

Artificial Intelligence (AI) in Radiology Market to Reach USD 4236 Million by 2031 | 9% CAGR Growth Driven by Cloud & On-Premise Solutions –...

Artificial Intelligence in Radiology Market is Segmented by Type (Cloud Based, On-Premise), by Application (Hospital, Biomedical Company, Academic Institution). BANGALORE, India , July 11, 2025 /PRNewswire/...

Artificial Intelligence (AI) in Radiology Market to Reach USD 4236 Million by 2031 | 9% CAGR Growth Driven by Cloud & On-Premise Solutions –...

Artificial Intelligence in Radiology Market is Segmented by Type (Cloud Based, On-Premise), by Application (Hospital, Biomedical Company, Academic Institution). BANGALORE, India , July 11, 2025 /PRNewswire/...

Brownfield Is the Real Test of Automation: How ForwardX Scaled 484 AMRs in a Live Auto OEM Factory Without Production Downtime

Health and Wellness Market Size to Hit $12.9 Trillion by 2031 Growing at a CAGR of 10.9%: Allied Market Research

Rosen Law Firm Encourages GoDaddy Inc. Investors to Inquire About Securities Class Action Investigation – GDDY

Sleep To Live Well Foundation Launches With Groundbreaking Sleep Wellness Report to Tackle National Epidemic and Transform Public Health

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors

Topflight Pharma Development Veteran Joins Synendos

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society’s Annual...

SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025

Regrowing hearing cells: New gene functions discovered in zebrafish offer clues for future hearing loss treatments

Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform

Artificial Intelligence (AI) in Radiology Market to Reach USD 4236 Million by 2031 | 9% CAGR Growth Driven by Cloud & On-Premise Solutions –...

Artificial Intelligence (AI) in Radiology Market to Reach USD 4236 Million by 2031 | 9% CAGR Growth Driven by Cloud & On-Premise Solutions –...

Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy

DR. DEANNA L. KELLY NAMED DIRECTOR OF THE MARYLAND PSYCHIATRIC RESEARCH CENTER

Botulinum Toxins Market worth $15.7 billion by 2030 with 11.7% CAGR | MarketsandMarkets™

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us